Rainier Acquisition Corporation
Searching since IPO 2026-08-27- CIK 2147219
- RNAQ
- IPO 2026-08-27
- 22 filings
- IPO Size
- $75M
- raised at the IPO
- Current Status
- Unit Split
- from its latest filing
- IPO Year
- 2026
- year it listed
Filings, by quarter
22 filings over 1 quarter; violet bars carry a milestone
- 26 Q3: 22 filings
- S-1 filed 26 Q3
- IPO 26 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
Rainier Acquisition Corporation is a blank-check company seeking a business combination, with a primary focus on global life sciences companies applying biology to improve human health, including therapeutics, diagnostics, genomics, precision medicine, life science tools, research services and biomanufacturing.
Investment Focus
Biopharmaceuticals, Healthcare
Key Information
As the filings state it
- IPO Date
- 2026-08-27
- Jurisdiction of Incorporation
- Cayman Islands
- SIC
- 6770
- SPAC Ticker
- RNAQ
Stock Performance
RNAQUTrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2026-08-27 | $10.02 | |
| Current Price | 2026-10-23 | $10.03 | +0% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team brings decades of life sciences investing, financing, operating and advisory experience, including public-company leadership and governance, capital markets, M&A and prior SPAC transactions. Its members include Gbola Amusa, Isaac Manke, Jonas Grossman, Andrew Lam and Guy Barudin.